Upstate Active Clinical Trials

Study Title:

A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum

What is the purpose of the study?

Randomized treatment study to look at the effect of combination chemotherapy in treating young patients with newly diagnosed high-risk acute lymphoblastic leukemia.

Upstate Institutional Review Board (IRB) Number:

275126

Study/Protocol ID:

AALL1131

Study Phase:

III

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT01406756

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again